4//SEC Filing
Kelsey Stephen Michael 4
Accession 0001610717-25-000054
CIK 0001628171other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 7:02 PM ET
Size
7.0 KB
Accession
0001610717-25-000054
Insider Transaction Report
Form 4
Kelsey Stephen Michael
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2025-03-01+128,100→ 128,100 totalExercise: $40.74Exp: 2035-02-28→ Common Stock (128,100 underlying) - Award
Common Stock
2025-03-01+36,600→ 296,345 total
Footnotes (2)
- [F1]Includes 113,926 restricted stock units.
- [F2]One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001462808
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 7:02 PM ET
- Size
- 7.0 KB